137 related articles for article (PubMed ID: 37516711)
21. ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines.
Bai R; Shi Z; Zhang JW; Li D; Zhu YL; Zheng S
J Zhejiang Univ Sci B; 2012 Nov; 13(11):884-93. PubMed ID: 23125081
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
[TBL] [Abstract][Full Text] [Related]
23. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
Shin HN; Moon HH; Ku JL
Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
[TBL] [Abstract][Full Text] [Related]
24. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
[TBL] [Abstract][Full Text] [Related]
25. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
26. Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling.
Margolin DA; Silinsky J; Grimes C; Spencer N; Aycock M; Green H; Cordova J; Davis NK; Driscoll T; Li L
Neoplasia; 2011 Sep; 13(9):874-86. PubMed ID: 21969820
[TBL] [Abstract][Full Text] [Related]
27. Role of visfatin in promoting proliferation and invasion of colorectal cancer cells by downregulating SDF-1/CXCR4-mediated miR-140-3p expression.
Zhao Q; Li JY; Zhang J; Long YX; Li YJ; Guo XD; Wei MN; Liu WJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5367-5377. PubMed ID: 32495871
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
[TBL] [Abstract][Full Text] [Related]
29. Triptolide inhibits migration and proliferation of fibroblasts from ileocolonic anastomosis of patients with Crohn's disease via regulating the miR‑16‑1/HSP70 pathway.
Chen M; Wang JM; Wang D; Wu R; Hou HW
Mol Med Rep; 2019 Jun; 19(6):4841-4851. PubMed ID: 30942423
[TBL] [Abstract][Full Text] [Related]
30. [Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
Xu J; Qian J; Zhang W; Chen E; Zhang G; Cao G; Wang F; Shen X; Zhou W; Song Z
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882644
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
32. The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.
Zheng F; Zhang Z; Flamini V; Jiang WG; Cui Y
Anticancer Res; 2017 Aug; 37(8):4361-4369. PubMed ID: 28739729
[TBL] [Abstract][Full Text] [Related]
33. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.
Li Z; Li N; Wu M; Li X; Luo Z; Wang X
Mol Cell Biochem; 2013 Sep; 381(1-2):233-42. PubMed ID: 23744532
[TBL] [Abstract][Full Text] [Related]
34. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
35. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
[TBL] [Abstract][Full Text] [Related]
36. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
[TBL] [Abstract][Full Text] [Related]
37. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of the Expression of c-FLIP
Li T; Li T; Zhang H; Liu C; Li M; Wang C; Zheng Y; Zhang L; Long X; Shi S; Long Y; Chen W
Front Biosci (Landmark Ed); 2023 Dec; 28(12):325. PubMed ID: 38179732
[TBL] [Abstract][Full Text] [Related]
40. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
